As of 2025-09-17, the Relative Valuation of Crescita Therapeutics Inc (CTX.TO) is (0.02) CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.46 CAD, the upside of Crescita Therapeutics Inc based on Relative Valuation is -103.9%.
The range of the Relative Valuation is (0.01) - (0.02) CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 0.2x - 0.3x | 0.2x |
| Forward P/E multiples | 0.2x - 0.3x | 0.2x |
| Fair Price | (0.01) - (0.02) | (0.02) |
| Upside | -103.1% - -104.7% | -103.9% |
| Date | P/E |
| 2025-09-11 | -6.45 |
| 2025-09-10 | -6.52 |
| 2025-09-08 | -6.52 |
| 2025-09-05 | -6.66 |
| 2025-09-03 | -6.80 |
| 2025-09-02 | -6.80 |
| 2025-08-29 | -6.52 |
| 2025-08-27 | -6.52 |
| 2025-08-26 | -6.52 |
| 2025-08-25 | -6.45 |
| 2025-08-22 | -6.52 |
| 2025-08-21 | -6.52 |
| 2025-08-20 | -6.52 |
| 2025-08-19 | -6.66 |
| 2025-08-15 | -7.01 |
| 2025-08-14 | -6.94 |
| 2025-08-13 | -6.52 |
| 2025-08-12 | -6.80 |
| 2025-08-11 | -6.37 |
| 2025-08-08 | -6.66 |
| 2025-08-07 | -6.66 |
| 2025-08-06 | -7.65 |
| 2025-08-05 | -6.66 |
| 2025-08-01 | -6.59 |
| 2025-07-30 | -6.59 |
| 2025-07-28 | -6.66 |
| 2025-07-24 | -6.66 |
| 2025-07-18 | -6.66 |
| 2025-07-17 | -6.59 |
| 2025-07-14 | -6.87 |
| 2025-07-09 | -6.87 |
| 2025-07-08 | -6.87 |
| 2025-07-07 | -6.87 |
| 2025-07-02 | -6.87 |
| 2025-06-30 | -7.01 |
| 2025-06-27 | -7.01 |
| 2025-06-25 | -6.94 |
| 2025-06-24 | -6.87 |
| 2025-06-20 | -6.87 |